← All stocks

Anika Therapeutics, Inc.

ANIK Net selling
CIK 0000898437 #3636 in the set updated 18 Sep 2026
Bought (120 mo)
$955.98K
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$10.14M
$0.00 on a plan · $196.10K straight out of an exercise
Sold at will
$9.94M
26 of 29 sales
Net
−$9.18M
−$8.99M against sales at will

By person

25 insiders · 47 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
SHERWOOD CHARLES H
CEO and Director
$6.47M (9)
−$6.47M
189,891
1.42%
$3.86M
−23.9%
Cheung Sylvia
Chief Financial Officer
$1.39M (4)
−$1.39M
49,281
0.3682%
$1.00M
+50.6%
LAND RAYMOND J
Director
$755.03K (6)
−$755.03K
12,125
0.0906%
$246.32K
−14.4%
Thompson Jeffery S
Director
$49.32K (1)
$782.68K (3)
−$733.36K
31,575
0.2359%
$641.45K
+111.2%
Hague Richard
Chief Commercial Officer
$286.02K (1)
−$286.02K
21,419
0.1600%
$435.13K
−25.9%
Larsen Glenn R.
Director
$249.15K (1)
−$249.15K
50,258
0.3755%
$1.02M
+1,021%
Levitz Michael L
EVP, CFO, Treasurer
$244.30K (3)
+$244.30K
46,955
0.3509%
$953.89K
+3,099%
Blanchard Cheryl R
Director
$207.14K (2)
+$207.14K
258,788
1.93%
$5.26M
HENNEMAN JOHN B III
Director
$159.04K (2)
+$159.04K
65,273
0.4877%
$1.33M
Griffin Stephen D.
President and CEO
$149.88K (1)
+$149.88K
45,973
0.3435%
$933.94K
+1,865%
Bower Joseph L.
Director
$134.24K (3)
−$134.24K
17,117
0.1279%
$347.73K
−53.7%
Colleran David
EVP, General Counsel, Corp Sec
$72.03K (2)
+$72.03K
67,570
0.5049%
$1.37M
+1,507%
Loerop James
EVP Business Development
$43.73K (1)
−$43.73K
5,592
0.0418%
$113.60K
Fischetti Gary P
Director
$41.06K (2)
+$41.06K
54,015
0.4036%
$1.10M
+2,228%
Darling Joseph G
President and CEO; Director
$33.20K (1)
+$33.20K
20,289
0.1516%
$412.17K
Ahn Edward S.
Chief Tech & Strategy Officer
$31.66K (1)
−$31.66K
6,575
0.0491%
$133.57K
−16.8%
Richard Stephen
Director
58,273
0.4354%
$1.18M
CONLEY SHERYL L
Director
52,970
0.3958%
$1.08M
VOGT SUSAN L N
Director
50,213
0.3752%
$1.02M
WHEELER STEVE E
Director
34,594
0.2585%
$702.78K
+4.8%
Capper Joseph H
Director
30,805
0.2302%
$625.80K
Finnerty Thomas
EVP, Human Resources
24,598
0.1838%
$499.71K
McLeod Ian
SVP, CAO & Treasurer
24,107
0.1801%
$489.73K
+40.3%
Nunes Anne
SVP, Chief Operations Officer
20,654
0.1543%
$419.59K
+228.6%
Jellison William R
Director
20,403
0.1525%
$414.49K
Insider
Date
Role
Action
Shares
Price
Amount
Fischetti Gary P
4 Aug 2026
Director
Buy
1,000
$20.32
$20.32K
Fischetti Gary P
3 Aug 2026
Director
Buy
1,000
$20.75
$20.75K
HENNEMAN JOHN B III
1 May 2026
Director
Buy
5,000
$14.66
$73.32K
Griffin Stephen D.
30 Apr 2026
President and CEO
Buy
12,200
$12.29
$149.88K
Colleran David
11 May 2022
EVP, General Counsel, Corp Sec
Buy
1,500
$21.37
$32.06K
Colleran David
14 Mar 2022
EVP, General Counsel, Corp Sec
Buy
1,500
$26.65
$39.98K
Levitz Michael L
11 Mar 2022
EVP, CFO, Treasurer
Buy
4,000
$24.62
$98.48K
Blanchard Cheryl R
11 Mar 2022
President, CEO, Director
Buy
3,813
$25.81
$98.43K
Blanchard Cheryl R
11 Mar 2022
President, CEO, Director
Buy
4,287
$25.36
$108.71K
Thompson Jeffery S
11 Mar 2022
Director
Buy
2,000
$24.66
$49.32K
Levitz Michael L
12 Aug 2021
EVP, CFO, Treasurer
Buy
777
$40.21
$31.24K
Levitz Michael L
11 Aug 2021
EVP, CFO, Treasurer
Buy
2,850
$40.21
$114.59K
HENNEMAN JOHN B III
18 May 2021
Director
Buy
2,000
$42.86
$85.72K
Darling Joseph G
28 Feb 2019
President and CEO; Director
Buy
1,000
$33.20
$33.20K

What was left out

Form 4 filings counted 209
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 3
Sales at will 26
Transactions with no price 0
Shares from compensation/vesting 1,428,889
Sales filed before the plan box existed 26
History held since 4 Nov 2016